首页> 外文期刊>Open Journal of Medicinal Chemistry >Synthesis and Anti-Cancer Activities of Resveratrol Derivatives
【24h】

Synthesis and Anti-Cancer Activities of Resveratrol Derivatives

机译:白藜芦醇衍生物的合成及抗癌活性

获取原文
       

摘要

A novel series of resveratrol derivatives were synthesized according to Wittig-Horner reaction with 3,5-dihydroxybenzyl alcohol or 3,5-dimethoxybenzyl alcohol or 4-hydroxybenzyl alcohol as raw material and the inhibitory activities on breast carcinoma (MDA-MB-231) and gastric carcinoma cell lines (SGC-7901) in vitro were evaluated by the standard methyl thiazole tetrazolium (MTT) method. The result of biological test shows that some of resveratrol derivatives possess stronger anti-cancer activities than 5-FU. Compound 5c shows the strongest activity against breast carcinoma (MDA-MB-231) and gastric carcinoma cell lines (SGC-7901) with IC50 value of 50.19 ± 1.02 μM, 122.68.27 ± 2.04 μM, compared to that IC50 value of 5-FU is 98.59±3.61 μM,156.74±6.16 μM, respectively.
机译:以3,5-二羟基苄醇或3,5-二甲氧基苄醇或4-羟基苄醇为原料,根据维蒂希-霍纳反应,合成了一系列新的白藜芦醇衍生物(MDA-MB-231)。通过标准甲基噻唑四唑(MTT)方法评估体外培养的胃癌细胞和胃癌细胞(SGC-7901)。生物学测试结果表明,白藜芦醇的某些衍生物具有比5-FU更强的抗癌活性。化合物5c对乳腺癌(MDA-MB-231)和胃癌细胞系(SGC-7901)表现出最强的活性,IC50值为50.19±1.02μM,122.68.27±2.04μM,而IC50值为5- FU分别为98.59±3.61μM,156.74±6.16μM。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号